flutemetamol f-18 · Ge Healthcare · NDA 203137
Vizamyl
Earliest generic entry, as listed
16 Sep 2028
Blocked by patent: US 8916131.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8916131 | product | 16 Sep 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 203137 · 001 · RLD · discontinued | injectable, intravenous | 40.5mCi/10ML (4.05mCi/ML) | 16 Sep 2028 |
| 203137 · 002 · RLD | injectable, intravenous | 121.5mCi/30ML (4.05mCi/ML) | 16 Sep 2028 |